Medartis’ Focus on Lower Extremities Drives Share Gains

Medartis reported 2H22 orthopedic sales of CHF 108.7 million ($118.5 million USD), +15.2% compared to the second half of 2022. The company generated CHF 212 million ($231.1 million USD) in orthopedic sales in 2023, growing 16% compared to the prior year.

The company demonstrated strength across three of its four sales regions in 2023. The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us